Sponsored by:
TAKEDA PHARMACEUTICALS NORTH AMERICA, INC.
One Takeda Parkway Deerfield, Illinois 60015 Phone: 224-554-6500
Top U.S. Hypertension Hot Spots Revealed
Hot Spots part of Commit to Control, a new program encouraging the
75 million Americans who have hypertension to get their high blood pressure under control
Deerfield, Ill., July 12, 2011 – A national analysis conducted by Sperling’s BestPlaces, sponsored
by Takeda Pharmaceuticals North America, Inc., identifies the nation’s Hypertension Hot Spots, or cities that face the most challenges due to hypertension risk factors and complications. Although hypertension is the second-leading preventable risk factor for death in the United States, it typically has no symptoms, and more than half of diagnosed patients with hypertension still do not have their blood pressures under control.
The Hypertension Hot Spots were identified as a way to educate Americans about the high
prevalence of hypertension and the risk factors associated with it. Identification of these Hot Spots are part of a larger Takeda-sponsored hypertension awareness program called Commit to Control, which educates Americans about hypertension and also challenges patients to do all they can to get their blood pressure under control. Patients can visit www.CommitToControl.com for tools and resources for managing hypertension, the chance to make a virtual pledge to better control it and more information on a traveling exhibit with free blood pressure screenings and an animated 3-D hypertension simulator.
Criteria used to determine the Hot Spots included prevalence rates of hypertension and
hypertension prescriptions per capita, as well as the prevalence of several lifestyle factors that may lead to the development of hypertension.
According to the analysis, the 10 metropolitan areas facing the most challenges due to hypertension are:
1. Memphis, Tenn./Miss./Ark.
2. Detroit-Livonia-Dearborn, Mich.
3. Louisville-Jefferson County, Ky./Ind.
4. Birmingham-Hoover, Ala.
5. Dayton, Ohio
6. Pittsburgh, Pa.
7. Buffalo-Niagara Falls, N.Y.
8. St. Louis, Mo./Ill.
9. Oklahoma City, Okla.
10. Tampa-St. Petersburg-Clearwater, Fla.
“The reality is hypertension is a widespread health concern that can lead to serious health
consequences such as stroke and heart attack if left uncontrolled,” said Michael Bloch, M.D., American Society of Hypertension board-certified clinical hypertension specialist from Reno, Nev.
“Hypertension is treatable, so there is no reason for patients to wait to begin lowering their blood pressure and get to goal.”
Patients can visit www.CommitToControl.com to see a full list of the 50 Hypertension Hot
Spots and to make an online pledge to talk to their doctors about controlling hypertension. For each pledge made online, Takeda will donate $5, up to $10,000, to Mended Hearts, a community- based, nationwide heart patient support network.
Later this year, Commit to Control will visit select Hypertension Hot Spots in the United
States. The local tour will provide free blood pressure screenings and a chance to personally see the effects hypertension can have on the body through an animated 3-D simulation. The tour schedule is available on the program website, which also provides patients with resources on how they can take small steps toward managing hypertension.
“Patients need to make a commitment to better understand how high blood pressure
impacts their health and then work with their doctors to get it under control through healthy lifestyle changes and regular blood pressure monitoring,” said Dr. Bloch. “I want to encourage patients to make the pledge online, or with their doctors, to better manage high blood pressure today.”
Takeda Pharmaceuticals North America, Inc., and Takeda Global Research & Development
Center, Inc. Based in Deerfield, Ill., Takeda Pharmaceuticals North America, Inc., and Takeda Global Research & Development Center, Inc. are subsidiaries of Takeda Pharmaceutical Company Limited, the largest pharmaceutical company in Japan.
To learn more about these Takeda companies, visit www.tpna.com.
# # #